Lack of induction of interleukin-2-receptor-α in patients with tuberculosis and human immunodeficiency virus co-infection: Implications for pathogenesis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 4, 2001, Pages 449-452

  Lawn, Stephen D ^a,c   Rudolph, Donna ^a   Ackah, Alain ^b   Coulibaly, Doulhourou ^b   Wiktor, Stefan ^b   Lal, Renu B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Project RETRO CI Abidjan   (Côte d’Ivoire)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C te d'Ivoire; Ghana; HIV; Immunodeficiency; Interleukin 2; Interleukin 2 receptor ; Tuberculosis; Tumour necrosis factor receptor I

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AIDS RELATED COMPLEX; ANIMAL; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; T LYMPHOCYTE; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0035407752     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90212-3     Document Type: Article

References (28)

1. Ackah, A. N., Coulibaly, D., Digbeu, H., Diallo, K., Vetter, K. M., Coulibaly, I. M., Greenberg, A. E. & De Cock, K. M. (1995). Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte D'Ivoire. Lancet, 345, 607-610.
2. Brown, A. E., Kuwanlaya, T., Rieder, T. & Webster, H. K. (1989). Prolonged elevations of soluble interleukin-2 receptors in tuberculosis. American Review of Respiratory Diseases, 139, 1036-1038.
3. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S. & Shearer, G. M. (1989). Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency seropositive patients. Journal of Clinical Investigation, 84, 1892-1899.
4. Crowe, S. M., Carlin, J. B., Stewart, K. I., Lucas, C. R. & Hoy, J. F. (1991). Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. Journal of the Acquired Immune Deficiency Syndrome, 4, 770-776.
5. Dannenberg, A. M. (1989). Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Reviews in Infectious Diseases, 11 (supplement 2), S369-S378.
6. Domoua, K., N'Dhatz, M., Coulibaly, G., Traore, G., Konan, J. B., Lucas, S., Beaumel, A., De Cock, K. M., Dago-Akribi, A. & Yapi, A. (1995). Autopsy findings in 70 AIDS patients who died in a department of pneumonology in Ivory Coast: impact of tuberculosis. Médecine Tropicale, 55, 252-254.
7. Elliott, A. M., Halwiindi, B., Hates, R. J., Nkandu, L., Tembo, G., Machiels, L., Bem, C., Steenbergen, G., Pobee, J. O. M., Nunn, P. P. & McAdam, P. W. J. (1993). The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. Journal of Tropical Medicine and Hygiene, 96, 1-11.
8. Hofmann, B., Nishanian, P., Fahey, J. L., Esmail, I., Jackson, A. L., Detels, R. & Cumberland, W. (1991). Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. Clinical Immunology and Immunopathology, 61, 212-224.
9. Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J. & Reed, J. C. (1986). Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science, 234, 1123-1127.
10. Jacobson, E. L., Pilaro, F. & Smith, K. A. (1996). Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proceedings of the National Academy of Sciences of the USA, 93, 10405-10410.
11. Johnson, B. J., Ress, S. R., Willcox, P., Pati, B. P., Lorgat, F., Stead, P., Saha, R., Lukey, P., Laochumroonvorapong, P. & Corral, L. (1995). Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 therapy. Cytokines and Molecular Therapy, 1, 185-196.
12. Lane, H. C., Depper, J. M., Greene, W. C., Whalen, G., Waldmann, T. A. & Fauci, A. S. (1985). Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine, 313, 79-84.
13. Law, K. F., Jagirdar, J., Weiden, M. D., Bodkin, M. & Rom, W. N. (1996). Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. American Journal of Respiratory and Critical Care Medicine, 153, 1377-1384.
14. Lawn, S. D., Evans, A. J., Sedgwick, P. M. & Acheampong, J. W. (1999). Pulmonary tuberculosis: radiological differences in West Africans coinfected with HIV. British Journal of Radiology, 71, 339-344.
15. Lawn, S. D., Labeta, M. O., Arias, M., Acheampong, J. W. & Griffin, G. E. (2000a). Elevated serum concentrations of soluble CD14 in HIV-negative and HIV-positive patients with tuberculosis in Africa: prolonged elevation during antituberculosis treatment. Clinical and Experimental Immunology, 120, 483-487.
16. 2-microglobulin, respectively. Clinical and Experimental Immunology, 122, 79-84.
17. Manca, F., Newell, A., Valle, M., Habeshaw, J. & Dalgleish, A. G. (1992). HIV-induced deletion of antigen-specific T cell function is MHC restricted. Clinical and Experimental Immunology, 87, 15-19.
18. Martinez-Maza, O., Crabb, E., Mitsuyasu, R. T., Fahey, J. L. & Giorgi, J. V. (1987). Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. Journal of Immunology, 138, 3720-3724.
19. Oyaizu, N., Chirmule, N., Vaniambadi, S., Kalyanaraman, S., Hall, W. W., Good, R. & Pahwa, S. (1990). Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proceedings of the National Academy of Sciences of the USA, 87, 2379-2383.
20. Puri, R. K., Leland, P. & Aggarwal, B. B. (1995). Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid line. AIDS Research and Human Retroviruses, 11, 31-40.
21. Rajalingam, R., Mehra, N. K., Pande, J. N., Jain, R. C. & Singla, R. (1996). Correlation of serum interleukin-2-receptor-α levels in pulmonary tuberculosis. Tubercle and Lung Disease, 77, 374-379.
22. Rosenberg, Z. F. & Fauci, A. S. (1989). The immunopathogenesis of HIV infection. Advances in Immunology, 47, 377-431.
23. Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R. & Nelson, D. L. (1985). Soluble interleukin-2-receptors are released from activated human lymphoid cells in vitro. Journal of Immunology, 135, 3172-3177.
24. Rubin, L. A., Galli, F., Greene, W. C., Nelson, D. L. & Jay, G. (1990). The molecular basis for the generation of the human soluble interleukin 2 receptor. Cytokine, 2, 330-336.
25. Smith, K. A. (1988). Interleukin-2: inception, impact and implications. Science, 240, 1169-1176.
26. Takahashi, S., Scoguchi, Y., Nukiwa, T. & Kira, S. (1991). Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis. Chest, 99, 310-314.
27. Waldmann, T. A. (1986). The structure, function and expression of interleukin-2-receptors on normal and malignant lymphocytes. Science, 232, 727-732.
28. Waldmann, T. A. (1991). The interleukin-2-receptor. Journal of Biological Chemistry, 26, 2681-2684.